Generated by Meeveem AI
"Pioneers non-invasive diagnostics connecting people to healthcare wherever they are"
OraSure Technologies develops non-invasive diagnostic tests and sample collection devices that make healthcare more accessible. The company specialises in rapid tests for infectious diseases including HIV, hepatitis C, COVID-19, and syphilis, alongside solutions that stabilise DNA and RNA from saliva, blood, and urine. These tools enable faster diagnosis at point of care, reducing barriers for patients, providers, and researchers. By decentralising diagnostics, OraSure addresses healthcare systems that remain distant or hard to access. Its products empower individuals to control their health and support public health programmes. The portfolio serves clinical and remote settings, expanding the reach of accurate health information.
501
Team Members
1987
Founded
Diagnostics
Sector
Hybrid
Work Environment
A world where healthcare is no longer confined to clinical settings, where diagnostic insight reaches every person regardless of location, and where timely, accurate health information empowers communities to prevent disease and improve lives.
Improving access, quality, and value of healthcare with innovation in effortless rapid tests and sample management solutions.